The company in question is, Sanofi (NYSE:SNY) currently with a stock price of 40.03 (-0.72% today). The market cap for Sanofi is 106146.03, and is in the sector Healthcare, and Drug Manufacturers – Major industry. The target price for Sanofi is 51.33. Currently Sanofi is trading with a P/E of 22.61, and a forward P/E of 13.24. Average volume for Sanofi is 2315.27 and so far today it is 678391.
Performance in the last year for Sanofi has been -22.85%. For EPS growth, Sanofi has seen a growth of 4.10%, and is looking to grow in the next year to -1.77%. More long term stats show that EPS growth has been -4.40% over the last five years and could be 7.40% for the next five years. Sanofi has seen sales growth quarter over quarter at -54.00%, with EPS growth quarter over quarter at -56.00%. The 20-day simple moving average is -2.23%, with the 200-day simple moving average coming to -1.69%.
Since the IPO date for Sanofi on the 7/1/2002, Sanofi has seen performance year to date to be -1.49%. With Sanofi trading at 40.03, the dividend yield is 4.12%, and the EPS is 1.78.
So could Sanofi, be undervalued? Well as said before P/E is 22.61. The PEG is 3.06, P/S is 2.77 and the P/B is at 1.71. The P/cash is 15.24, with P/free cash flow at *TBA.
Sanofi ability to deal with debt shows that the current ratio is 1.5, and the quick ratio is 1. This is with long term debt/equity at 0.27, and total debt/equity at 0.32.
In terms of margins, Sanofi has a gross margin of 68.90%, an operating margin of *TBA and a profit margin of *TBA.Payout ratio for Sanofi is *TBA. Return on assets come to *TBA with return on investment coming to 6.50%.
Insider ownership for Sanofi, is at 16.40% and institutional ownership comes to 9.70%. Outstanding shares are at 2632.59. While shares float is 2303.87. The float short is currently 0.23%, and short ratio is 2.27.